statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024 Virax Biolabs Launches Portfolio of Immune Profiling...

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Unlock the potential of adaptive immunity with ImmuneSelect by Virax Biolabs. Investigate T-Cell driven immunity for post-viral syndromes like Long COVID. Explore peptide pools and recombinant...

EXCLUSIVE: Virax Biolabs Launches Immune Profiling Solutions To Evaluate Adaptive Immunity In Post-Viral Syndromes

Virax Biolabs to Participate at ESCMID Global 2024 Virax Biolabs to Participate at ESCMID Global 2024 PR Newswire LONDON, April 16, 2024 LONDON, April 16, 2024 /PRNewswire/ -- Virax Biolabs Group...

Virax Biolabs to Participate at ESCMID Global 2024

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price...

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency

Virax Biolabs Group Limited (NASDAQ:VRAX  Get Free Report) saw a significant decline in short interest in January. As of January 15th, there was short interest totalling 30,100 shares, a...

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Update

Virax Biolabs Group Limited (NASDAQ:VRAX  Get Free Report) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest...

Virax Biolabs Group Limited (NASDAQ:VRAX) Sees Large Growth in Short Interest

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Volume	18,360.00
52-Wk High	$5.45
52-Wk Low	$0.6133

VRAX VIRAX BIOLABS GROUP LIMITED

About

Feed

News

Fundamentals